Edition:
India

People: CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

18.70HKD
9:38am IST
Change (% chg)

HK$-0.22 (-1.16%)
Prev Close
HK$18.92
Open
HK$18.90
Day's High
HK$18.96
Day's Low
HK$18.50
Volume
9,500,257
Avg. Vol
36,930,684
52-wk High
HK$21.80
52-wk Low
HK$11.22

Wang, Qingxi 

Dr. Wang Qingxi serves as Executive Director of the Company. Dr. Wang is also a director of certain subsidiaries of the Group. Prior to joining the Group, Dr. Wang worked at Merck & Co., Inc. in the U.S. for 20 years where he held senior positions including director of pharmaceutical R&D and director of business development and operation. Dr. Wang holds a bachelor’s degree in science (chemistry) and a master’s degree in science (chemistry) from Nankai University in China, a master’s degree in science (polymer science) and a doctorate in chemistry from University of Connecticut in the U.S. and a MBA degree from Temple University in the U.S..

Basic Compensation

Total Annual Compensation, HKD 1,686,000
Restricted Stock Award, HKD --
Long-Term Incentive Plans, HKD --
All Other, HKD 6,000
Fiscal Year Total, HKD 1,692,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Dongchen Cai

13,805,000

Cuilong Zhang

4,326,000

Kin Man Chak

5,269,000

Chunlei Li

4,783,000

Hua Lu

4,205,000

Weidong Pan

4,387,000
As Of  31 Dec 2018